EFMC-ASMC'17

Conferences > Upcoming events > EFMC-ASMC'17

Confirmed Speakers


Confirmed Invited Speakers

Ring Construction by Pd-catalyzed C(sp3)-H Activation
 Olivier BAUDOIN Olivier BAUDOIN
(UNIVERSITY OF BASEL, Basel, Switzerland)

Read more
Azidoperfluoroalkanes - Neglected, Stable and Useful Fluorinated Synthons
  Petr BEIER Petr BEIER
(ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, Prague, Czech Republic)

Read more
Opening Lecture - Next-Generation Small Molecule Therapeutics
 James E BRADNER James E BRADNER
(NOVARTIS INSTITUTES FR BIOMEDICAL RESEARCH, Cambridge, MA, United States)

Read more
Drugging the Undruggable
 Mark BUNNAGE Mark BUNNAGE
(VERTEX PHARMACEUTICALS, Boston, United States)

Read more
Beta-secretase Inhibitors as a Therapy for Alzheimer’s Disease – Where Are We Now?
 Roland BÜRLI Roland BÜRLI
(ASTRAZENECA, Cambridge, United Kingdom)

Read more
Medicinal Chemistry of Small and Larger Synthetic Molecules – Case studies
 Werngard CZECHTIZKY Werngard CZECHTIZKY
(SANOFI-AVENTIS DEUTSCHLAND GMBH, Frankfurt, Germany)

Read more
Collaborative Academic/Industrial Research Under the Umbrella of the NSF Center for Selective C-H Functionalization
 Huw DAVIES Huw DAVIES
( EMORY UNIVERSITY, Atlanta, United States)

Read more
Synthetic, Mechanistic and Computational Studies on Reactions of Interest
 Scott E. DENMARK Scott E. DENMARK
(UNIVERSITY OF ILLINOIS, Urbana, United States)

Read more
Recent Advances in Isosteric-Switch Strategies
 Thomas C. FESSARD Thomas C. FESSARD
(SPIROCHEM AG, Zurich, Switzerland)

Read more
DNA Repair Inhibition in Cancer Therapy: DNA-PK Inhibitor M3814
 Thomas FUCHSS Thomas FUCHSS
(MERCK KGAA, Darmstadt, Germany)

Read more
Exploiting Physical Organic Principles in Reaction Design
 Ryan GILMOUR Ryan GILMOUR
(UNIVERSITY OF MÜNSTER, Münster, Germany)

Read more
Late Stage 18F-Fluorination for PET Imaging
 Véronique GOUVERNEUR Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)

Read more
Automation, integration and miniaturization In Drug Discovery Synthesis
 Guido KOCH Guido KOCH
(NOVARTIS PHARMA AG, Basel, Switzerland)

Read more
When Chemistry Asks Biological Questions: Total Synthesis on the Driving Seat
 Nuno MAULIDE Nuno MAULIDE
(UNIVERSITY OF VIENNA, Vienna, Austria)

Read more
Antiviral Drug Design
 Nicholas MEANWELL Nicholas MEANWELL
(BRISTOL-MYERS SQUIBB, Wallingford, United States)

Read more
Recent Advances in Methods Development and Applications
 Gary A. MOLANDER Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)

Read more
Idea2Data: Augmenting Drug Discovery Efforts through Synthetic Reaction Data Mining and Automation
 Christos A. NICOLAOU Christos A. NICOLAOU
(ELI LILLY, Indianapolis, United States)

Read more
With Asymmetric Hydrogenation towards a Scalable, Stereoselective Synthesis of Bitopertin
 Michelangelo SCALONE Michelangelo SCALONE
(F. HOFFMANN-LA ROCHE AG, Basel, Switzerland)

Read more
Title to be announced
Adventures in Catalysis: from Mechanisms to Applications
 Franziska SCHOENEBECK Franziska SCHOENEBECK
(RWTH AACHEN, Aachen, Germany)

Read more
Strategies towards Increasing the 3-Dimensionality of the Medicinal Chemistry Design Space
 Antonia STEPAN Antonia STEPAN
(PFIZER, Cambridge, United States)

Read more
A RaPID Way to Discover Pseudo-natural Peptides for Therapeutic Uses
 Hiroaki SUGA Hiroaki SUGA
(UNIVERSITY OF TOKYO, Tokyo, Japan)

Read more
Controlling Biological Pathways With Photopharmacology
 Dirk TRAUNER Dirk TRAUNER
(NEW YORK UNIVERSITY, New York, United States)

Read more
Design and Evolution of New Biocatalysts for Organic Synthesis
 Nicholas John TURNER Nicholas John TURNER
(UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)

Read more
Merck Drug Discovery through Enabling Capabilities
 Petr VACHAL Petr VACHAL
(MSD, Kenilworth, United States)

Read more
Bioinspired Asymmetric Catalysis
 Helma WENNEMERS Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)

Read more
Strategies to Facilitate the Discovery of Novel CNS Positron Emission Tomography (PET) Ligands
 Lei ZHANG Lei ZHANG
(PFIZER, Cambridge, United States)

Read more

Oral Communications

Development of Synthesis Strategies to DNA-Encoded Compound Libraries - of a Chemoresistant Sequence, and Micellar Nanoreactors
 Andreas BRUNSCHWEIGER Andreas BRUNSCHWEIGER
(TU DORTMUND, Dortmund, Germany)

Read more
Expanding Screening Decks by Innovative MCR Scaffolds
 Alexander DÖMLING Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, RUG, Groningen, The Netherlands)

Read more
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
 Peter ETTMAYER Peter ETTMAYER
(BOEHRINGER-INGELHEIM, Vienna, Austria)

Read more
Stereoselective Peptide Modifications – Efficient Tools for Natural Product and Drug Synthesis
 Uli KAZMAIER Uli KAZMAIER
(SAARLAND UNIVERSITY, Saarbrücken, Germany)

Read more
Mimicking Nature Complexity with 3D-Fragments Assembly
 Hugues LEMOINE Hugues LEMOINE
(EDELRIS, LYON, France)

Read more
Discovery of UCB0942, the First Rationally Designed Antiepileptic Drug with a Dual Mechanism of Action for the Treatment of Drug-Resistant Epilepsy
 Laurent PROVINS Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)

Read more
The Discovery of Soluble Guanylate Cyclase Stimulators for the Treatment of Pulmonary Arterial Hypertension
 Subharekha RAGHAVAN Subharekha RAGHAVAN
(MSD, Kenilworth, New Jersey, United States)
Discovery of RG7314, a Vasopressin 1a Receptor Antagonist for the Treatment of Social Communication Deficits in Autism Spectrum Disorders
 Patrick SCHNIDER Patrick SCHNIDER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)

Read more
Exploring New Methods for Facile Synthesis of Some Biologically Interesting Molecules
 Ming-Hua XU Ming-Hua XU
(SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, China)

Read more

Organised by

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Media Partners

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys